IN8bio partners with UofL’s Dunbar CAR T-Cell Program as the Manufacturing Center for INB-400

IN8bio, Inc., a clinical-stage biopharmaceutical company discovering and developing innovative gamma-delta T-cell therapies that utilize its DeltEx platform, has selected the UofL Health – Brown Cancer Center GMP Manufacturing Facility at the University of Louisville as its manufacturing partner for INB-400.
[University of Louisville]
Press Release

Stay up-to-date with your field!

Subscribe for free weekly science newsletters.

Related News